b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">28643275</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>11</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Print">2192-8304</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>38</Volume>\n                    <PubDate>\n                        <Year>2018</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>JIMD reports</Title>\n                <ISOAbbreviation>JIMD Rep</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>81-88</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/8904_2017_29</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although nitisinone is successfully used to treat hereditary tyrosinemia type 1 (HT-1) with the recommended twice-daily dosing, data describing a long half-life motivate less frequent dosing. Therefore, in agreement with the Pharmacovigilance Risk Assessment Committee at the European Medicines Agency, this study was performed to investigate the switch to once-daily dosing.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">This open-label, non-randomized, single-sequence crossover study evaluated the pharmacokinetics, efficacy, and safety of once-daily compared to twice-daily dosing of nitisinone in patients with HT-1 (NCT02323529). Well-controlled patients of &lt;2, 2 to &lt;12, 12 to &lt;18, and \xe2\x89\xa518\xc2\xa0years of age who were on twice-daily dosing were eligible for participation. Nitisinone and succinylacetone levels were determined from dry blood spots by tandem mass spectrometry. The primary endpoint was C<sub>min</sub> of nitisinone after \xe2\x89\xa54 weeks of treatment on each dosing regimen. Secondary objectives were evaluation of efficacy and safety during each dosing regimen.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 19 patients were enrolled and 17 included in the per-protocol analysis set. The mean (SD) nitisinone C<sub>min</sub> decreased by 23%, from 26.4 (10.2) to 21.2 (9.9) \xce\xbcmol/L in dry blood spot samples (not equivalent to plasma concentrations), when patients switched from twice- to once-daily dosing. There was no apparent age- or bodyweight-related trend in the degree of C<sub>min</sub> decrease. No patient had quantifiable succinylacetone levels during the once-daily treatment period, indicating efficacious treatment. All adverse events were mild or moderate and judged unrelated to nitisinone.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The switch to once-daily treatment with nitisinone appeared efficacious and safe in the treatment of patients with HT-1.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Guffon</LastName>\n                    <ForeName>Nathalie</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Centre de R\xc3\xa9f\xc3\xa9rence des Maladies H\xc3\xa9r\xc3\xa9ditaires du M\xc3\xa9tabolisme, H\xc3\xb4pital Femme M\xc3\xa8re Enfant, 59 Boulevard Pinel, 69677, Bron, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Br\xc3\xb6ijers\xc3\xa9n</LastName>\n                    <ForeName>Anders</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden. anders.broijersen@sobi.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Palmgren</LastName>\n                    <ForeName>Ingrid</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rudebeck</LastName>\n                    <ForeName>Mattias</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Olsson</LastName>\n                    <ForeName>Birgitta</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Swedish Orphan Biovitrum (Sobi), 112 76, Stockholm, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>06</Month>\n                <Day>23</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>JIMD Rep</MedlineTA>\n            <NlmUniqueID>101568557</NlmUniqueID>\n            <ISSNLinking>2192-8304</ISSNLinking>\n        </MedlineJournalInfo>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>01</Month>\n                <Day>26</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>04</Month>\n                <Day>18</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>04</Month>\n                <Day>12</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>6</Month>\n                <Day>24</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2017</Year>\n                <Month>6</Month>\n                <Day>24</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>6</Month>\n                <Day>24</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">28643275</ArticleId>\n            <ArticleId IdType="doi">10.1007/8904_2017_29</ArticleId>\n            <ArticleId IdType="pmc">PMC5874213</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Inherit Metab Dis. 2012 Sep;35(5):831-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22307209</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 1977 Oct;74(10):4641-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">270706</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Med Genet. 2017 Apr;54(4):241-247</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27876694</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Dis Child Fetal Neonatal Ed. 1996 May;74(3):F191-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8777683</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Clin Pharmacol. 2001 Aug;52(2):169-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11488774</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Chem. 2008 Apr;54(4):657-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18281422</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Chim Acta. 2011 May 12;412(11-12):873-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21216241</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Appl Pharmacol. 1996 Dec;141(2):439-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8975769</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Liver Dis. 2000 Nov;4(4):805-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11232358</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Ther. 2002 Feb;24(2):302-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11911560</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicol Appl Pharmacol. 1995 Jul;133(1):12-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7597701</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Biochem. 2004 Nov;37(11):1010-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15498530</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Manag Care Pharm. 2012 Sep;18(7):527-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22971206</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Orphanet J Rare Dis. 2016 Jun 29;11(1):87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27356512</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Chim Acta. 2011 Jan 14;412(1-2):134-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20883679</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rapid Commun Mass Spectrom. 2008;22(6):812-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18278819</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JIMD Rep. 2015;24:21-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25772318</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FEBS Lett. 1993 Mar 1;318(2):162-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8382628</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Genet Metab. 2012 Sep;107(1-2):49-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22885033</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Orphanet J Rare Dis. 2014 Aug 01;9:107</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25081276</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Orphanet J Rare Dis. 2013 Jan 11;8:8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23311542</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Genet Metab. 2014 Sep-Oct;113(1-2):67-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25066104</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'